Effect of heparin thromboprophylaxis on thrombin generation in multiple myeloma patients

被引：5
|
作者：
Chalayer, Emilie [1 ,2 ]
Tardy-Poncet, Brigitte [3 ]
Montmartin, Aurelie [3 ]
Boussoualim, Karima [1 ]
Genthon, Alexis [1 ]
Tardy, Bernard [2 ]
机构：
[1] Inst Cancerol Lucien Neuwirth, Dept Hematol, St Priest En Jarez, France
[2] CHU St Etienne, Ctr Invest Clin, CIC 1408, Inserm, St Etienne, France
[3] Univ J Monnet, Equipe DVH, INSERM U1059, St Etienne, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2019年 / 186卷 / 02期
关键词：
venous thrombosis; neoplasm; low-molecular-weight heparin; multiple myeloma; lymphoma; coagulation tests; ASPIRIN;
D O I：
10.1111/bjh.15815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：337 / 339
页数：3
相关论文
共 50 条
  • [21] Thrombin generation post elective caesarean section: Effect of low molecular weight heparin
    Ismail, Siti K.
    Norris, Lucy
    Muttukrishna, Shanthi
    Higgins, John R.
    THROMBOSIS RESEARCH, 2012, 130 (05) : 799 - 803
  • [22] Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
    Leclerc, V
    Karlin, L.
    Herledan, C.
    Marchal, L.
    Baudouin, A.
    Gouraud, A.
    Caffin, A. G.
    Larbre, V
    Lazareth, A.
    Bachy, E.
    Salles, G.
    Ghesquieres, H.
    Rioufol, C.
    Ranchon, F.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 975 - 984
  • [23] Thromboembolic events and thromboprophylaxis associated with immunomodulators in multiple myeloma patients: a real-life study
    V. Leclerc
    L. Karlin
    C. Herledan
    L. Marchal
    A. Baudouin
    A. Gouraud
    A. G. Caffin
    V. Larbre
    A. Lazareth
    E. Bachy
    G. Salles
    H. Ghesquières
    C. Rioufol
    F. Ranchon
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 975 - 984
  • [24] What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial
    Zara Sayar
    Julia Czuprynska
    Jignesh P. Patel
    Reuben Benjamin
    Lara N. Roberts
    Raj K. Patel
    Victoria Cornelius
    Roopen Arya
    Journal of Thrombosis and Thrombolysis, 2019, 48 : 315 - 322
  • [25] The effect on thrombin generation and anti-Xa levels of thromboprophylaxis dose adjustment in post-cesarean obese patients - A prospective cohort study
    Rottenstreich, Amihai
    Levin, Gabriel
    Elchalal, Uriel
    Kleinstern, Geffen
    Spectre, Galia
    Ziv, Esther
    Yagel, Simcha
    Kalish, Yosef
    THROMBOSIS RESEARCH, 2018, 170 : 69 - 74
  • [26] What are the difficulties in conducting randomised controlled trials of thromboprophylaxis in myeloma patients and how can we address these? Lessons from apixaban versus LMWH or aspirin as thromboprophylaxis in newly diagnosed multiple myeloma (TiMM) feasibility clinical trial
    Sayar, Zara
    Czuprynska, Julia
    Patel, Jignesh P.
    Benjamin, Reuben
    Roberts, Lara N.
    Patel, Raj K.
    Cornelius, Victoria
    Arya, Roopen
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (02) : 315 - 322
  • [27] Serum thrombin activatable fibrinolysis inhibitor levels in patients with newly diagnosed multiple myeloma
    Balcik, Ozlem S.
    Albayrak, Murat
    Uyar, Mehtap E.
    Dagdas, Simten
    Yokus, Osman
    Ceran, Funda
    Cipil, Handan
    Kosar, Ali
    Ozet, Gulsum
    BLOOD COAGULATION & FIBRINOLYSIS, 2011, 22 (04) : 260 - 263
  • [28] Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis
    Greinacher, Andreas
    Warkentin, Theodore E.
    EXPERT REVIEW OF HEMATOLOGY, 2008, 1 (01) : 75 - 85
  • [29] Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines
    Charalampous, Charalampos
    Shah, Darshi
    Kumar, Shaji
    Chakraborty, Rajshekhar
    ANNALS OF HEMATOLOGY, 2024, 103 (10) : 3881 - 3888
  • [30] Newly diagnosed multiple myeloma: Do we need to propose thromboprophylaxis?
    Chalayer, E.
    Augeul-Meunier, K.
    Tardy-Poncet, B.
    Cathebras, P.
    Guyotat, D.
    Tardy, B.
    REVUE DE MEDECINE INTERNE, 2012, 33 (12): : 693 - 696
12345